Cortical Kynurenine Pathway Metabolism: A Novel Target for Cognitive Enhancement in Schizophrenia von WONODI, Ikwunga, SCHWARCZ, Robert

Volltext

The kynurenine pathway of tryptophan degradation as a drug target von Schwarcz, Robert

Volltext

Xanthurenic Acid Formation from 3-Hydroxykynurenine in the Mammalian Brain: Neurochemical Characterization and Physiological Effects von Sathyasaikumar, K.V., Tararina, M., Wu, H.-Q., Neale, S.A., Weisz, F., Salt, T.E., Schwarcz, R.

Volltext

Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex von Bortz, D.M., Wu, H.-Q., Schwarcz, R., Bruno, J.P.

Volltext

N-Acetylcysteine Inhibits Kynurenine Aminotransferase II von Blanco-Ayala, T., Sathyasaikumar, K.V., Uys, J.D., Pérez-de-la-Cruz, V., Pidugu, L.S., Schwarcz, R.

Volltext

Astrocyte-derived kynurenic acid modulates basal and evoked cortical acetylcholine release von Zmarowski, A., Wu, H.-Q., Brooks, J. M., Potter, M. C., Pellicciari, R., Schwarcz, R., Bruno, J. P.

Volltext

Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain? von Wu, H-Q, Rassoulpour, A, Schwarcz, R

Volltext

Targeting Kynurenine Aminotransferase II in Psychiatric Diseases: Promising Effects of an Orally Active Enzyme Inhibitor von WU, Hui-Qiu, OKUYAMA, Masahiro, KAJII, Yasushi, POCIVAVSEK, Ana, BRUNO, John P, SCHWARCZ, Robert

Volltext

Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: Reversal with galantamine von Alexander, K.S, Pocivavsek, A, Wu, H.-Q, Pershing, M.L, Schwarcz, R, Bruno, J.P

Volltext

Toxoplasma gondii and Schizophrenia: Linkage Through Astrocyte-Derived Kynurenic Acid? von Schwarcz, Robert, Hunter, Christopher A.

Volltext

Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum von Amori, L, Wu, H.-Q, Marinozzi, M, Pellicciari, R, Guidetti, P, Schwarcz, R

Volltext

Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry von Konradsson-Geuken, Å, Wu, H.Q, Gash, C.R, Alexander, K.S, Campbell, A, Sozeri, Y, Pellicciari, R, Schwarcz, R, Bruno, J.P

Volltext

Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease von Guidetti, Paolo, Luthi-Carter, Ruth E., Augood, Sarah J., Schwarcz, Robert

Volltext

Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: Implications for schizophrenia von Notarangelo, F.M, Wilson, E.H, Horning, K.J, Thomas, M.A.R, Harris, T.H, Fang, Q, Hunter, C.A, Schwarcz, R

Volltext

Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain von Ceresoli-Borroni, G, Rassoulpour, A, Wu, H-Q, Guidetti, P, Schwarcz, R

Volltext

Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N -methyl- d -aspartate neurotoxicity von Poeggeler, B, Rassoulpour, A, Wu, H.-Q, Guidetti, P, Roberts, R.C, Schwarcz, R

Volltext

Kynurenate production by cultured human astrocytes von KISS, C, CERESOLI-BORRONI, G, GUIDETTI, P, ZIELKE, C. L, ZIELKE, H. R, SCHWARCZ, R

Volltext

Importance of kynurenine 3-monooxygenase for spontaneous firing and pharmacological responses of midbrain dopamine neurons: Relevance for schizophrenia von Tufvesson-Alm, Maximilian, Schwieler, Lilly, Schwarcz, Robert, Goiny, Michel, Erhardt, Sophie, Engberg, Göran

Volltext

Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia von Sathyasaikumar, Korrapati V., Stachowski, Erin K., Wonodi, Ikwunga, Roberts, Rosalinda C., Rassoulpour, Arash, McMahon, Robert P., Schwarcz, Robert

Volltext

Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease von Schwarcz, Robert, Guidetti, Paolo, Sathyasaikumar, Korrapati V, Muchowski, Paul J

Volltext